Acorda Therapeutics, Inc. - stock earnings
ACOR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -8.9 million USD | 27.7 million USD |
| 2023Q2 | -9.4 million USD | 29.7 million USD |
| 2023Q1 | -16.8 million USD | 22.3 million USD |
| 2022Q4 | 19.1 million USD | 31.5 million USD |
| 2022Q3 | -13.9 million USD | 33.5 million USD |
| 2022Q2 | -46.7 million USD | 31.1 million USD |
| 2022Q1 | -24.5 million USD | 22.5 million USD |
| 2021Q4 | -20.6 million USD | 37.0 million USD |
| 2021Q3 | -27.1 million USD | 31.5 million USD |
| 2021Q2 | -22.9 million USD | 31.8 million USD |
| 2021Q1 | -33.5 million USD | 28.9 million USD |
| 2020Q4 | -83.0 million USD | 38.2 million USD |
| 2020Q3 | 7.3 million USD | 53.1 million USD |
| 2020Q2 | -17.4 million USD | 33.6 million USD |
| 2020Q1 | -6.5 million USD | 28.1 million USD |
| 2019Q4 | 65.7 million USD | 50.5 million USD |
| 2019Q3 | -263.5 million USD | 47.7 million USD |
| 2019Q2 | -27.5 million USD | 50.1 million USD |
| 2019Q1 | -47.6 million USD | 44.1 million USD |
| 2018Q4 | 9.6 million USD | 69.2 million USD |
| 2018Q3 | -13.9 million USD | 142.8 million USD |
| 2018Q2 | 46.2 million USD | 153.3 million USD |
| 2018Q1 | -8.2 million USD | 106.2 million USD |
| 2017Q4 | -171.1 million USD | 188.4 million USD |
| 2017Q3 | -25.2 million USD | 141.1 million USD |
| 2017Q2 | -8.2 million USD | 139.4 million USD |
| 2017Q1 | -18.9 million USD | 119.4 million USD |
| 2016Q4 | -3.1 million USD | 140.6 million USD |
| 2016Q3 | -12.7 million USD | 135.6 million USD |
| 2016Q2 | -18.3 million USD | 127.5 million USD |
| 2016Q1 | -520000 USD | 115.9 million USD |
| 2015Q4 | 9.2 million USD | 130.9 million USD |
| 2015Q3 | 3.9 million USD | 148.2 million USD |
| 2015Q2 | 997000 USD | 113.7 million USD |
| 2015Q1 | -3.1 million USD | 99.9 million USD |
| 2014Q4 | 331000 USD | 117.9 million USD |
| 2014Q3 | 12.0 million USD | 106.0 million USD |
| 2014Q2 | 4.7 million USD | 97.1 million USD |
| 2014Q1 | 703000 USD | 80.5 million USD |
| 2013Q4 | 6.2 million USD | 92.6 million USD |
| 2013Q3 | 7.5 million USD | 84.9 million USD |
| 2013Q2 | 3.9 million USD | 87.1 million USD |
| 2013Q1 | -1.1 million USD | 71.9 million USD |
| 2012Q4 | 133.0 million USD | 81.5 million USD |
| 2012Q3 | 9.6 million USD | 77.4 million USD |
| 2012Q2 | 4.5 million USD | 75.7 million USD |
| 2012Q1 | 7.8 million USD | 71.2 million USD |
| 2011Q4 | 12.7 million USD | 72.6 million USD |
| 2011Q3 | 18.9 million USD | 93.0 million USD |
| 2011Q2 | -285000 USD | 65.3 million USD |
| 2011Q1 | -672000 USD | 61.3 million USD |
| 2010Q4 | 3.7 million USD | 66.8 million USD |
| 2010Q3 | 12.4 million USD | 63.6 million USD |
| 2010Q2 | -6.8 million USD | 42.8 million USD |
| 2010Q1 | -21.1 million USD | 17.7 million USD |
| 2009Q4 | -22.5 million USD | 14.4 million USD |
| 2009Q3 | -19.4 million USD | 15.2 million USD |
| 2009Q2 | -23.3 million USD | 12.6 million USD |
| 2009Q1 | -18.7 million USD | 12.5 million USD |
| 2008Q4 | -20.2 million USD | 12.5 million USD |
| 2008Q3 | -18.9 million USD | 12.5 million USD |
| 2008Q2 | -18.8 million USD | 11.4 million USD |
| 2008Q1 | -16.4 million USD | 11.5 million USD |
| 2007Q4 | -13.7 million USD | 11.2 million USD |
| 2007Q3 | -8.5 million USD | 10.5 million USD |
| 2007Q2 | -8.2 million USD | 9.5 million USD |
| 2007Q1 | -7.5 million USD | 8.3 million USD |
| 2006Q4 | -7.0 million USD | 7.7 million USD |
| 2006Q3 | -7.2 million USD | 6.2 million USD |
| 2006Q2 | -2.9 million USD | 9.6 million USD |
| 2006Q1 | -6.9 million USD | 3.8 million USD |
| 2005Q4 | -9.6 million USD | 2.7 million USD |
| 2005Q3 | -8.7 million USD | 810575 USD |
| 2003Q3 | -23.2 million USD | 201704 USD |
ACOR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.0 million USD | 111.1 million USD |
| 2022 | -65.9 million USD | 118.6 million USD |
| 2021 | -104.0 million USD | 129.1 million USD |
| 2020 | -99.6 million USD | 153.0 million USD |
| 2019 | -273.0 million USD | 192.4 million USD |
| 2018 | 33.7 million USD | 471.4 million USD |
| 2017 | -223.4 million USD | 588.3 million USD |
| 2016 | -34.6 million USD | 519.6 million USD |
| 2015 | 11.1 million USD | 492.7 million USD |
| 2014 | 17.7 million USD | 401.5 million USD |
| 2013 | 16.4 million USD | 336.4 million USD |
| 2012 | 155.0 million USD | 305.8 million USD |
| 2011 | 30.6 million USD | 292.2 million USD |
| 2010 | -11.8 million USD | 191.0 million USD |
| 2009 | -83.9 million USD | 54.7 million USD |
| 2008 | -74.3 million USD | 47.8 million USD |
| 2007 | -38.0 million USD | 39.5 million USD |
| 2006 | -24.0 million USD | 27.4 million USD |
| 2005 | -35.5 million USD | 5.1 million USD |
| 2004 | -44.7 million USD | 479495 USD |
| 2003 | -62.4 million USD | 856000 USD |
| 2002 | -25.7 million USD | 473588 USD |
ACOR
Price: $0.66
52 week price:
Payout Ratio Range:
Earnings Per Share: -203.57 USD
P/E Ratio: 5.98
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 250200
Ebitda: -218.1 millionMarket Capitalization: 821028